2Cameron N E,Eaton S E,Cotter M A, et al . Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy[J]. Diabetologia, 2001,44(11) : 1973-1988.
3Haler M C, Ivey F M, Gyure K A, et al. Thrombomodulin deficiency in human diabetic nerve microvasculature [J]. Diabetes, 2002,51(6): 1957-1963.
4Aso Y, Fujiwara Y, Tayama K, a al. Elevation of von Willebrand factor in plasma in diabetic patients with neuropathic foot ulceration[J]. Diabet Med, 2002,19(1) : 19-26.
5Nakayama M, Nakamaru J, Hamada Y, a al . Aldose reductase inhibition ameliorates pupillary light reflex and F-wave latency in patients with mild diabetic neuropathy[J]. Diabetes Care,2001,24(6) : 1093-1098.
6Zochodne D W. Diabetic neuropathies : features and mechanisms[J]. Brain Pathol,1999,9(2) :369-391.
7Verrotti A,Giuva P T, Morgese G, et al . New trends in the etipathogenesis of diabetic peripheral neuropathy[J]. J Child Neurol, 2001,16(6) : 389-394.
8Conti G, Scarpini E, Baron P, mal . Macrophage infiltration and death in the nerve during the early phases of experimental diabetic neuropathy: a process concomitant with endoneurial induction of IL-lbeta and p75NTR[J]. J Neurol Sci, 2002,195(1) : 35-40.
9Skundric D S, Dai R, James J, mal. Activation of IL-1 signaling pathway in Schwann cells during diabetic neuropathy [J]. AnnNYAcadSci, 2002,958(2): 393-398.
10Rask C A. Biological actions of nerve growths factors in the peripheral nervous system[J]. Eur neurol, 1999,41( Supple 1) :14-19.
